Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
about
Carcinoid tumorsPositron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringNon-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosynthesesRecent developments in imaging of pancreatic neuroendocrine tumorsCurrent knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumoursImaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentImaging of gastroenteropancreatic neuroendocrine tumorsDetection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case reportItalian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management.Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.Multimodal management of neuroendocrine liver metastases.Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications.Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.Patient with synchronous low grade leiomyosarcoma of the thigh, primary pancreatic neuroendocrine tumor, and lung metastases: Why biopsy of metastases should be the standardUptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver LesionsAtypical or typical adrenocorticotropic hormone-producing pulmonary carcinoids and the usefulness of 11C-5-hydroxytryptophan positron emission tomography: two case reports.A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.Update on nuclear medicine imaging of neuroendocrine tumors.The current role of PET-CT in the characterization of hepatobiliary malignancies.Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up.Molecular imaging of neuroendocrine tumorsNordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.Imaging the islet graft by positron emission tomography.ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas.Role of PET/CT in the functional imaging of endocrine pancreatic tumors.Nuclear medicine in NET.Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
P2860
Q24614827-83044B98-1774-4A89-A344-212D9F12E8E2Q26765882-BA3A4619-DBA4-4602-AB19-0742989B26C4Q26795597-8A45C517-A862-4B20-B958-DCCD21862BDDQ26991479-55A4BDA7-5972-4BAA-8D4E-B1251B720926Q27005697-73F84A2A-705E-4A74-B4C0-30ED28C362F0Q28071483-56783873-D596-4089-AD19-3C3C67B7F17CQ28083433-C15D6665-B0E1-4D59-BA4A-B43C0E905675Q28238305-7EC08965-8F84-4C09-B190-039393F2BB3EQ33569093-BC78A423-FBF6-4B30-A463-E3CFD20EA3FDQ34157385-D2836642-E128-4999-BDF7-87BB52637571Q34248466-C695F8B3-1487-4A5F-AE9F-18D23896373DQ34248487-717D228F-C799-4276-AC0B-FBD0B4EB6A6BQ34256413-67A2EC17-5C32-4577-9BA5-D3A57D1D8360Q34301030-D8768600-EEA6-45C3-93E0-CCD50556ADC3Q34389590-D1F49A48-1F8B-4E0A-952F-70D20AB6C285Q34513678-AB46E15B-460D-4B43-8A13-C8F4311AA77DQ34528199-6F48522B-7716-44D5-84EB-2D3BBDF0E26CQ34557208-F4DC5DD8-3B32-43AC-94A2-0119078B8F39Q35201548-01573AF0-B8F8-4301-8D0C-584FDA9486ACQ35760798-7096553B-1F1C-4DD3-B25F-A14A1A476933Q35801361-3B0B11E7-A691-4F25-8AD8-A98ECBEE71E6Q35869517-DE25A9D4-20F3-41E7-81CC-0500FFD9073FQ35895493-15DE9DC9-713B-49F8-885A-814CCFF39A57Q36084862-232E0BB3-40F1-4470-9BB0-7AD3E6C486A5Q36097160-9154E88C-1432-4F41-BD82-0DD1EFBFCBA8Q36556526-2C7B22F9-55D0-4534-960D-B17B15675DB4Q36716779-B3DF7118-0814-4807-8B2A-0779E09EEBB9Q37002905-239824AB-6440-4F6D-B219-88CE26E15DBBQ37401346-687BD4ED-3E55-4D41-A130-579CC7F76DEFQ37546832-4A535ED9-C024-44C9-A4A7-3D0F4D549198Q37612715-468E29B6-91FC-4206-A44D-D5C6A01F318CQ37675588-D60ABE17-599E-4B9C-98E2-4A3F3380B043Q37730951-AC90A8F3-B5B5-4A9A-9BF6-4707F839CDF9Q37765569-569DB610-812B-4E08-A9A8-A6568CAEFBB6Q37935646-EC89E277-7ECC-4146-886D-F8BBCF19BC24Q37977337-1C64B7E8-7312-404B-9013-C9A50C6B2CACQ37994083-63C78863-416B-4312-9090-D08FC22D8412Q38027393-3F17C372-294D-4FC8-9602-DE84170D6887Q38036127-784FB7CB-0DE1-4144-8580-9D845A364329Q38082417-63D885ED-4023-4F7A-85D5-001CADB01FC5
P2860
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Improved staging of patients w ...... positron emission tomography.
@en
Improved staging of patients w ...... positron emission tomography.
@nl
type
label
Improved staging of patients w ...... positron emission tomography.
@en
Improved staging of patients w ...... positron emission tomography.
@nl
prefLabel
Improved staging of patients w ...... positron emission tomography.
@en
Improved staging of patients w ...... positron emission tomography.
@nl
P2093
P356
P1476
Improved staging of patients w ...... n positron emission tomography
@en
P2093
Adrienne H Brouwers
Elisabeth G E de Vries
Ido P Kema
Koen Vanghillewe
Oliver C Neels
Philip H Elsinga
Pieter L Jager
Wim J Sluiter
P304
P356
10.1200/JCO.2007.15.1126
P407
P577
2008-03-01T00:00:00Z